Department of Ophthalmology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
The Rotterdam Eye Hospital and Rotterdam Ophthalmic Institute, Rotterdam, the Netherlands.
Invest Ophthalmol Vis Sci. 2024 Aug 1;65(10):40. doi: 10.1167/iovs.65.10.40.
Gene-based therapies for inherited retinal dystrophies (IRDs) are upcoming. Treatment before substantial vision loss will optimize outcomes. It is crucial to identify common phenotypes and causative genes in children. This study investigated the frequency of these in pediatric IRD with the aim of highlighting relevant groups for future therapy.
Diagnostic, genetic, and demographic data, collected from medical charts of patients with IRD aged up to 20 years (n = 624, 63% male), registered in the Dutch RD5000 database, were analyzed to determine frequencies of phenotypes and genetic causes. Phenotypes were categorized as nonsyndromic (progressive and stationary IRD) and syndromic IRD. Genetic causes, mostly determined by whole-exome sequencing (WES), were examined. Additionally, we investigated the utility of periodic reanalysis of WES data in genetically unresolved cases.
Median age at registration was 13 years (interquartile range, 9-16). Retinitis pigmentosa (RP; n = 123, 20%), Leber congenital amaurosis (LCA; n = 97, 16%), X-linked retinoschisis (n = 64, 10%), and achromatopsia (n = 63, 10%) were the most frequent phenotypes. The genetic cause was identified in 76% of the genetically examined patients (n = 473). The most frequently disease-causing genes were RS1 (n = 32, 9%), CEP290 (n = 28, 8%), CNGB3 (n = 21, 6%), and CRB1 (n = 17, 5%). Diagnostic yield after reanalysis of genetic data increased by 7%.
As in most countries, RP and LCA are the most prominent pediatric IRDs in the Netherlands, and variants in RS1 and CEP290 were the most prominent IRD genotypes. Our findings can guide therapy development to target the diseases and genes with the greatest needs in young patients.
遗传性视网膜营养不良(IRDs)的基因治疗即将出现。在视力明显下降之前进行治疗将优化治疗效果。因此,确定儿童中常见的表型和致病基因至关重要。本研究旨在调查儿科 IRD 中的这些表型和致病基因的频率,以突出未来治疗的相关人群。
分析了荷兰 RD5000 数据库中登记的年龄在 20 岁以下(63%为男性)的 IRD 患者(n=624)的诊断、遗传和人口统计学数据,以确定表型和遗传病因的频率。表型分为非综合征性(进行性和静止性 IRD)和综合征性 IRD。遗传病因主要通过全外显子组测序(WES)确定。此外,我们还研究了在遗传未解决的病例中定期重新分析 WES 数据的效用。
登记时的中位年龄为 13 岁(四分位距,9-16)。最常见的表型为色素性视网膜炎(RP;n=123,20%)、先天性黑矇(LCA;n=97,16%)、X 连锁性视网膜劈裂(n=64,10%)和色盲(n=63,10%)。在接受基因检查的患者中(n=473),76%确定了遗传病因。最常导致疾病的基因是 RS1(n=32,9%)、CEP290(n=28,8%)、CNGB3(n=21,6%)和 CRB1(n=17,5%)。重新分析遗传数据后,诊断率提高了 7%。
与大多数国家一样,RP 和 LCA 是荷兰最常见的儿科 IRD,RS1 和 CEP290 的变异是最常见的 IRD 基因型。我们的发现可以指导治疗开发,针对年轻患者中最需要的疾病和基因。